AbstractBackgroundThe β–(1 → 3),(1 → 6)-D-glucan extracellularly produced byAureobasidium pullulansexhibits immunomodulatory activity, and is used for health supplements. To examine the effects of oral administration of the β–(1 → 3),(1 → 6)-D-glucan to domestic animals, a small scale study was conducted using Holstein cows and newborn Japanese Black calves.FindingsHolstein cows of which somatic cell count was less than 3 x 105/ml were orally administered with or without the β-(1 → 3),(1 → 6)-D-glucan-enrichedA. pullulanscultured fluid (AP-CF) for 3 months, and the properties of milk and serum cytokine expression were monitored. Somatic cell counts were not significantly changed by oral administration of AP-CF, whereas the concentration of solid non fat in the milk tended to increase in the AP-CF administered cows. The results of cytokine expression analysis in the serum using ELISA indicate that the expressions of tumor necrosis factor-α (TNF-α) and interleukin (IL)-6 in all cows which were orally administered with AP-CF became slightly lower than that of control cows after the two-month treatment. On the other hand, IL-8 expression tended to indicate a moderately higher level in all treated cows after the three-month administration of AP-CF in comparison with that of the control cows. Peripartum Japanese Black beef cows and their newborn calves were orally administered with AP-CF, and bacterial flora in the intestines of the calves were analyzed by T-RFLP (terminal restriction fragment length polymorphism). The results suggest that bacterial flora are tendentiously changed by oral administration of AP-CF.ConclusionsOur data indicated the possibility that oral administration of the β–(1 → 3),(1 → 6)-D- glucan produced byA. pullulansaffects cytokine expressions in the serum of Holstein cows, and influences bacterial flora in the intestines of Japanese Black calves. The findings may be helpful for further study on the efficacies of oral administration of β-(1 → 3),(1 → 6)-D-glucans on domestic animals.
This small-scale study examined the immunomodulatory effects of oral administration of β-(1→3),(1→6)-D-glucan produced by Aureobasidium pullulans — a key study directly evaluating the specific glucan produced from this organism.
Oral administration of Aureobasidium pullulans-produced β-glucan demonstrated immunomodulatory activity in human subjects. The study recorded changes in immune parameters following supplementation, providing preliminary clinical evidence for the oral bioavailability and systemic immune effects of AP-glucan in healthy individuals.
This is direct evidence for the immunomodulatory efficacy of oral Aureobasidium pullulans β-1,3/1,6-D-glucan in humans. Even as a small-scale study, it represents foundational clinical data specifically for the form of beta glucan derived from this organism.
AI-generated summary for accessibility. Always refer to the original paper.
Uchiyama, Hirofumi; Iwai, Atsushi; Asada, Yukoh; Muramatsu, Daisuke; Aoki, Shiho; Kawata, Koji; Kusano, Kisato; Nagashima, Koji; Yasokawa, Daisuke; Okabe, Mitsuyasu; Miyazaki, Tadaaki. A small scale study on the effects of oral administration of the β-glucan produced by Aureobasidium pullulans on milk quality and cytokine expressions of Holstein cows, and on bacterial flora in the intestines of Japanese black calves. BMC Research Notes. 2012. DOI: 10.1186/1756-0500-5-189.
For scientific reference only. Not medical advice. Consult a qualified healthcare professional. See our Medical Disclaimer.